In LUAD, ADAM9 is notably overexpressed and was shown to promote tumor growth in xenograft models by regulating angiogenic factors such as vascular endothelial growth factor A, interleukin-8, and angiopoietin-2 [13,14]. The gene discussed is ADAM9; the disease is neoplasm.